Skip to main content
Log in

Effects of intranasal steroid treatment on the presence of biofilms in non-allergic patients with chronic rhinosinusitis with nasal polyposis

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Microbial biofilms have been implicated in the pathogenesis of chronic rhinosinusitis with nasal polyposis (CRSwNP). Intranasal application of corticosteroids (INCS) is a reliable option in the management of CRSwNP. INCS medication has been suspected to influence the presence and thickness of microbial biofilms and inflammatory cell patterns in CRSwNP. Two series of identical nasal polyps obtained from non-allergic patients with CRSwNP (n = 56), who underwent endoscopic sinus surgery (ESS), were processed to hematoxylin–eosin (H.E.) and Gram staining, respectively. Patients were recruited into three groups. Group A (n = 21) consisted of patients with continuous preoperative INCS treatment. In group B (n = 17), patients were never treated by INCS, while in group C (n = 18) INCS medication was stopped at least 6 months before ESS. Biofilm positivity varied from 76.4 to 88.8 % in different subject groups. These values and average thickness of biofilms did not reach statistically significant levels (Mann–Whitney’s U probe, p > 0.05) in different patient groups. In contrast, microscopic pattern and numbers of predominant inflammatory cell populations displayed obvious differences according to INCS treatment (Mann–Whitney’s U probe, p < 0.001). According to these observations, INCS treatment does not affect the presence and thickness of microbial biofilms in CRSwNP. In contrast, it has significant effects on the pattern of inflammatory cells infiltrating the subepithelial layer, which might result in beneficially altered extracellular matrix production and cytokine release.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Meltzer EO, Hamilos DL (2011) Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc 86:427–443

    Article  PubMed Central  PubMed  Google Scholar 

  2. Aouad RK, Chiu AG (2011) State of the art treatment of nasal polyposis. Am J Rhinol Allergy 25:291–298

    Article  PubMed  Google Scholar 

  3. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, de Wang Y, Wormald PJ (2012) European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl 23:1–298

    Google Scholar 

  4. Eloy P, Poirrier AL, De Dorlodot C, Van Zele T, Watelet JB, Bertrand B (2011) Actual concepts in rhinosinusitis: a review of clinical presentations, inflammatory pathways, cytokine profiles, remodeling, and management. Curr Allergy Asthma Rep 11:146–162

    Article  CAS  PubMed  Google Scholar 

  5. Al-Mutairi D, Kilty SJ (2011) Bacterial biofilms and the pathophysiology of chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 11:18–23

    Article  PubMed  Google Scholar 

  6. Galli J, Calò L, Ardito F, Imperiali M, Bassotti E, Passali GC, La Torre G, Paludetti G, Fadda G (2008) Damage to ciliated epithelium in chronic rhinosinusitis: what is the role of bacterial biofilms? Ann Otol Rhinol Laryngol 117:902–908

    PubMed  Google Scholar 

  7. Mullol J, Picado C (2013) Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease. Immunol Allergy Clin North Am 33:163–176

    Article  PubMed  Google Scholar 

  8. Karosi T, Csomor P, Sziklai I (2012) Tumor necrosis factor-α receptor expression correlates with mucosal changes and biofilm presence in chronic rhinosinusitis with nasal polyposis. Laryngoscope 122:504–510

    Article  CAS  PubMed  Google Scholar 

  9. Ayers CM, Schlosser RJ, O’Connell BP, Atkinson C, Mulligan RM, Casey SE, Bleier BS, Wang EW, Sansoni ER, Kuhlen JL, Mulligan JK (2011) Increased presence of dendritic cells and dendritic cell chemokines in the sinus mucosa of chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis. Int Forum Allergy Rhinol 1:296–302

    Article  PubMed  Google Scholar 

  10. Hekiert AM, Kofonow JM, Doghramji L, Kennedy DW, Chiu AG, Palmer JN, Leid JG, Cohen NA (2009) Biofilms correlate with TH1 inflammation in the sinonasal tissue of patients with chronic rhinosinusitis. Otolaryngol Head Neck Surg 141:448–453

    Article  PubMed  Google Scholar 

  11. Zernotti ME, Angel Villegas N, Roques Revol M, Baena-Cagnani CE, Arce Miranda JE, Paredes ME, Albesa I, Paraje MG (2010) Evidence of bacterial biofilms in nasal polyposis. J Investig Allergol Clin Immunol 5:380–385

    Google Scholar 

  12. Nonaka M, Ogihara N, Fukumoto A, Sakanushi A, Kusama K, Pawankar R, Yagi T (2010) Nasal polyp fibroblasts produce MIP-3alpha in response to toll-like receptor ligands and cytokine stimulation. Rhinology 48:41–46

    PubMed  Google Scholar 

  13. Tóth L, Csomor P, Sziklai I, Karosi T (2011) Biofilm detection in chronic rhinosinusitis by combined application of hematoxylin-eosin and gram staining. Eur Arch Otorhinolaryngol 268:1455–1462

    Article  PubMed  Google Scholar 

  14. Potter PC, Pawankar R (2012) Indications, efficacy, and safety of intranasal corticosteroids in rhinosinusitis. World Allergy Organ J 5:14–17

    Google Scholar 

  15. Stjärne P, Mösges R, Jorissen M, Passàli D, Bellussi L, Staudinger H, Danzig M (2006) A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg 132:179–185

    Article  PubMed  Google Scholar 

  16. Vento SI, Blomgren K, Hytönen M, Simola M, Malmberg H (2012) Prevention of relapses of nasal polyposis with intranasal triamcinolone acetonide after polyp surgery: a prospective double-blind, placebo-controlled, randomised study with a 9-month follow-up. Clin Otolaryngol 37:117–123

    Article  CAS  PubMed  Google Scholar 

  17. Ho CY, Chan KT (2009) Effects of intranasal steroid spray in bacterial culture of chronic rhinosinusitis. Am J Rhinol Allergy 23:405–408

    Article  PubMed  Google Scholar 

  18. Hochstim CJ, Choi JY, Lowe D, Masood R, Rice DH (2010) Biofilm detection with hematoxylin-eosin staining. Arch Otolaryngol Head Neck Surg 136:453–456

    Article  PubMed  Google Scholar 

  19. Psaltis AJ, Ha KR, Beule AG, Tan LW, Wormald PJ (2007) Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis. Laryngoscope 117:1302–1306

    Article  PubMed  Google Scholar 

  20. Bottari B, Ercolini D, Gatti M, Neviani E (2006) Application of FISH technology for microbiological analysis: current state and prospects. Appl Microbiol Biotechnol 73:485–494

    Article  CAS  PubMed  Google Scholar 

  21. Lennard CM, Mann EA, Sun LL, Chang AS, Bolger WE (2000) Interleukin-1 beta, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis: response to systemic corticosteroids. Am J Rhinol 14:367–373

    Article  CAS  PubMed  Google Scholar 

  22. Bobic S, van Drunen CM, Callebaut I, Hox V, Jorissen M, Fokkens WJ, Hellings PW (2010) Dexamethasone-induced apoptosis of freshly isolated human nasal epithelial cells concomitant with abrogation of IL-8 production. Rhinology 48:401–407

    CAS  PubMed  Google Scholar 

  23. Yariktas M, Doner F, Sutcu R, Demirci M, Dogru H, Yasan H (2005) The effect of topical corticosteroid on basic fibroblast growth factor in nasal polyp tissue. Am J Rhinol 19:248–250

    PubMed  Google Scholar 

  24. Kato A, Peters A, Suh L, Carter R, Harris KE, Chandra R, Conley D, Grammer LC, Kern R, Schleimer RP (2008) Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 121:1385–1392

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Li HB, Cai KM, Liu Z, Xia JH, Zhang Y, Xu R, Xu G (2008) Foxp3+ T regulatory cells (Tregs) are increased in nasal polyps (NP) after treatment with intranasal steroid. Clin Immunol 129:394–400

    Article  CAS  PubMed  Google Scholar 

  26. Molet SM, Hamid QA, Hamilos DL (2003) IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope 113:1803–1812

    Article  CAS  PubMed  Google Scholar 

  27. Hamilos DL, Thawley SE, Kramper MA, Kamil A, Hamid QA (1999) Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease. J Allergy Clin Immunol 103:79–87

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the grants of Hungarian Scientific Research Fund (OTKA PD75371 and OTKA K108292).

Conflict of Interest

Authors have no conflicts of interest.

Ethical Standard

This study was approved by the Institutional Ethical Committee.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tamás Karosi.

Additional information

All authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Csomor, P., Sziklai, I. & Karosi, T. Effects of intranasal steroid treatment on the presence of biofilms in non-allergic patients with chronic rhinosinusitis with nasal polyposis. Eur Arch Otorhinolaryngol 271, 1057–1065 (2014). https://doi.org/10.1007/s00405-013-2666-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-013-2666-y

Keywords

Navigation